SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001052918-21-000215
Filing Date
2021-06-17
Accepted
2021-06-17 17:07:48
Documents
14
Period of Report
2020-04-30

Document Format Files

Seq Description Document Type Size
1 AVRICORE HEALTH INC. avricore6kapril2020.htm 6-K 12212
2 EXHIBIT 99.1 nr_ex99z1.htm EX-99.1 11281
3 EXHIBIT 99.2 financials_ex99z2.htm EX-99.2 340245
4 EXHIBIT 99.3 mda_ex99z3.htm EX-99.3 116991
5 EXHIBIT 99.4 ceocert_ex99z4.htm EX-99.4 6008
6 EXHIBIT 99.5 cfocert_ex99z5.htm EX-99.5 5996
7 EXHIBIT 99.6 partfee_ex99z6.htm EX-99.6 2104
8 IMAGE nrex99z1_1.jpg GRAPHIC 6914
9 IMAGE financialsex99z2_1.jpg GRAPHIC 6599
10 IMAGE mdaex99z3_1.jpg GRAPHIC 6671
11 IMAGE partfeeex99z6_1.jpg GRAPHIC 140612
12 IMAGE partfeeex99z6_2.jpg GRAPHIC 139066
13 IMAGE partfeeex99z6_3.jpg GRAPHIC 156810
14 IMAGE partfeeex99z6_4.jpg GRAPHIC 42730
  Complete submission text file 0001052918-21-000215.txt   1184706
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 211025662
SIC: 2834 Pharmaceutical Preparations